CRISPR Therapeutics AG (CRSP)
NASDAQ: CRSP · Real-Time Price · USD
46.04
-1.23 (-2.59%)
Nov 21, 2024, 11:56 AM EST - Market open
CRISPR Therapeutics AG Employees
CRISPR Therapeutics AG had 407 employees as of December 31, 2023. The number of employees decreased by 51 or -11.14% compared to the previous year.
Employees
407
Change (1Y)
-51
Growth (1Y)
-11.14%
Revenue / Employee
$498,351
Profits / Employee
-$588,683
Market Cap
3.93B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
ICU Medical | 14,000 |
Organon & Co. | 10,000 |
Haemonetics | 3,657 |
Sotera Health Company | 3,000 |
Oscar Health | 2,400 |
Ultragenyx Pharmaceutical | 1,276 |
Prestige Consumer Healthcare | 570 |
BridgeBio Pharma | 556 |
CRSP News
- 14 hours ago - CRISPR Therapeutics AG (CRSP) Jefferies London Healthcare Conference (Transcript) - Seeking Alpha
- 6 days ago - CRISPR Therapeutics AG (CRSP) Guggenheim Inaugural Healthcare Innovation Conference (Transcript) - Seeking Alpha
- 7 days ago - CRISPR Therapeutics to Present at the Jefferies London Healthcare Conference - GlobeNewsWire
- 9 days ago - Crispr Therapeutics Q3 Earnings: No Casgevy Revenue, But Plenty Of Optimism - Seeking Alpha
- 16 days ago - CRISPR Therapeutics Provides Business Update and Reports Third Quarter 2024 Financial Results - GlobeNewsWire
- 24 days ago - Crispr Therapeutics: Poised For A Major Turnaround - Seeking Alpha
- 6 weeks ago - Buying Opportunities In Biotech And Pharma With Bhavneesh Sharma - Seeking Alpha
- 2 months ago - Crispr Therapeutics: Prepare To Be Bored - Seeking Alpha